Patents Assigned to NVH Medicinal
  • Collagen-based injectable preparations capable of controlling bleeding and/or of substituting for platelets in the case of haemorrhagic syndromes
    Patent number: 9878018
    Abstract: The present invention relates to an injectable preparation comprising particles or fibrils with length less than 10 ?m and at least one pharmaceutically acceptable vehicle or excipient. The particles or fibrils comprise proteins or peptides inducing adhesion and activation of the platelets, or even aggregation thereof. The preparation is useful for treating hemorrhages.
    Type: Grant
    Filed: December 11, 2014
    Date of Patent: January 30, 2018
    Assignees: NVH Medicinal, Centre Hospitalier Universitaire De Dijon
    Inventors: David Vandroux, Laure Dumont, Emmanuel De Maistre
  • Collagen-derived recombinant proteins with von Willebrand factor-binding activity
    Patent number: 9581603
    Abstract: A method for diagnosing von Willebrand disease and novel polypeptides which bind to von Willebrand factor.
    Type: Grant
    Filed: October 18, 2013
    Date of Patent: February 28, 2017
    Assignees: NVH Medicinal, Centre Hospitalier Universitaire De Dijon
    Inventors: David Vandroux, Emmanuel De Maistre, Francois Coutard, Laure Dumont Di Leone